Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | Eos Energy Enterprises, Inc. EOSE | Point72 Asset Management, L.P. | 3,840,704 2.000% | -1,694,326 (-30.61%) | Filing History |
| 2024-02-14 10:02 am Sale | 2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 62,511 1.400% | -130,889 (-67.68%) | Filing History |
| 2024-02-14 10:02 am Purchase | 2023-12-31 | 13G | Avalo Therapeutics, Inc. AVTX | Point72 Asset Management, L.P. | 2,500 0.300% | 2,500 (New Position) | Filing History |
| 2024-02-14 10:01 am Sale | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 788,545 3.000% | -1,335,655 (-62.88%) | Filing History |
| 2024-02-14 08:56 am Sale | 2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Point72 Asset Management, L.P. | 822,334 3.000% | -743,495 (-47.48%) | Filing History |
| 2024-02-14 07:16 am Purchase | 2023-12-31 | 13G | FARFETCH LTD FTCHQ | Point72 Asset Management, L.P. | 20,383,303 5.800% | 1,617,894 (+8.62%) | Filing History |
| 2024-02-14 07:15 am Sale | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 2,613,453 4.500% | -572,624 (-17.97%) | Filing History |
| 2024-02-14 07:15 am Sale | 2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Point72 Asset Management, L.P. | 3,202,381 4.700% | -268,310 (-7.73%) | Filing History |
| 2024-02-14 07:01 am Purchase | 2023-12-31 | 13G | Semtech Corporation SMTC | Point72 Asset Management, L.P. | 1,684,160 2.600% | 1,684,160 (New Position) | Filing History |
| 2024-02-14 07:01 am Sale | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 2,834,499 3.300% | -685,903 (-19.48%) | Filing History |
| 2024-02-14 07:00 am Sale | 2023-12-31 | 13G | Biohaven Ltd. BHVN | Point72 Asset Management, L.P. | 2,552,822 3.200% | -1,508,521 (-37.14%) | Filing History |
| 2024-02-14 06:45 am Sale | 2023-12-31 | 13G | Bionomics Limited BNOX | Point72 Asset Management, L.P. | 4,965,000 4.000% | -4,959,390 (-49.97%) | Filing History |
| 2024-02-14 06:45 am Sale | 2023-12-31 | 13G | Rapid7, Inc. RPD | Point72 Asset Management, L.P. | 1,877,611 3.100% | -1,214,659 (-39.28%) | Filing History |
| 2024-02-14 06:30 am Sale | 2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 3,997,545 4.500% | -87,999 (-2.15%) | Filing History |
| 2024-02-14 06:30 am Sale | 2023-12-31 | 13G | Chewy, Inc. CHWY | Point72 Asset Management, L.P. | 1,591,442 1.300% | -5,114,441 (-76.27%) | Filing History |
| 2024-02-14 06:29 am Sale | 2023-12-31 | 13G | Inari Medical, Inc. NARI | Point72 Asset Management, L.P. | 1,175,150 2.000% | -1,620,202 (-57.96%) | Filing History |
| 2024-02-14 06:17 am Sale | 2023-12-31 | 13G | Pulmonx Corporation LUNG | Point72 Asset Management, L.P. | 1,546,089 4.000% | -425,721 (-21.59%) | Filing History |
| 2024-02-14 06:16 am Sale | 2023-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Point72 Asset Management, L.P. | 468,821 0.200% | -7,646,069 (-94.22%) | Filing History |
| 2024-02-14 06:15 am Sale | 2023-12-31 | 13G | Fastly, Inc. FSLY | Point72 Asset Management, L.P. | 68,184 0.100% | -6,141,507 (-98.90%) | Filing History |
| 2024-02-14 06:11 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 209,971 0.200% | -4,323,785 (-95.37%) | Filing History |